Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bowden

Showing results (401-410 of 444) with videos related to

Pageof 45
Sort By:
The Australian and New Zealand Journal of Psychiatry|April 30, 2016
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorderOle Köhler, Louisa G Sylvia, Charles L Bowden, et al.
Arthritis Care & Research|October 28, 2024
Building the OAChangeMap to Improve the Service Delivery of the New South Wales Osteoarthritis Chronic Care Program: A Worked Example of Using a Codesign FrameworkJillian P Eyles, Sarah Kobayashi, Vicky Duong, et al.
Acta Psychiatrica Scandinavica|March 8, 2013
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trialD E Kemp, L G Sylvia, J R Calabrese, et al.
Arthritis Care & Research|October 7, 2022
Effectiveness of a New Service Delivery Model for Management of Knee Osteoarthritis in Primary Care: A Cluster Randomized Controlled TrialDavid J Hunter, Jocelyn L Bowden, Rana S Hinman, et al.
The American Journal of Psychiatry|July 5, 2005
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trialMauricio Tohen, Waldemar Greil, Joseph R Calabrese, et al.
The Australian and New Zealand Journal of Psychiatry|February 15, 2022
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changesOle Köhler-Forsberg, Louisa G Sylvia, Michael Thase, et al.
Acta Neuropsychiatrica|June 7, 2019
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trialsOle Köhler-Forsberg, Louisa G Sylvia, Charles L Bowden, et al.
Journal of Psychiatric Research|October 19, 2015
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR)Michael J Ostacher, Andrew A Nierenberg, Dustin Rabideau, et al.
Psychiatry Research|September 9, 2021
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-responseOle Köhler-Forsberg, Kirstine H Sloth, Louisa G Sylvia, et al.
Depression and Anxiety|June 30, 2020
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trialsOle Köhler-Forsberg, Louisa G Sylvia, Vicki Fung, et al.
Pageof 45

Showing results (401-410 of 444) with videos related to

Sort By:
Pageof 45
The Australian and New Zealand Journal of Psychiatry|April 30, 2016
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorderOle Köhler, Louisa G Sylvia, Charles L Bowden, et al.
Arthritis Care & Research|October 28, 2024
Building the OAChangeMap to Improve the Service Delivery of the New South Wales Osteoarthritis Chronic Care Program: A Worked Example of Using a Codesign FrameworkJillian P Eyles, Sarah Kobayashi, Vicky Duong, et al.
Acta Psychiatrica Scandinavica|March 8, 2013
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trialD E Kemp, L G Sylvia, J R Calabrese, et al.
Arthritis Care & Research|October 7, 2022
Effectiveness of a New Service Delivery Model for Management of Knee Osteoarthritis in Primary Care: A Cluster Randomized Controlled TrialDavid J Hunter, Jocelyn L Bowden, Rana S Hinman, et al.
The American Journal of Psychiatry|July 5, 2005
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trialMauricio Tohen, Waldemar Greil, Joseph R Calabrese, et al.
The Australian and New Zealand Journal of Psychiatry|February 15, 2022
Lithium plus antipsychotics or anticonvulsants for bipolar disorder: Comparing clinical response and metabolic changesOle Köhler-Forsberg, Louisa G Sylvia, Michael Thase, et al.
Acta Neuropsychiatrica|June 7, 2019
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trialsOle Köhler-Forsberg, Louisa G Sylvia, Charles L Bowden, et al.
Journal of Psychiatric Research|October 19, 2015
A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR)Michael J Ostacher, Andrew A Nierenberg, Dustin Rabideau, et al.
Psychiatry Research|September 9, 2021
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-responseOle Köhler-Forsberg, Kirstine H Sloth, Louisa G Sylvia, et al.
Depression and Anxiety|June 30, 2020
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trialsOle Köhler-Forsberg, Louisa G Sylvia, Vicki Fung, et al.
Pageof 45